MarketFriction

Jupiter Bioscience Ltd

BSE 524826 · Commodity Chemicals
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Sales91121154178233331
Expenses49708690113185
Operating Profit42516888119146
OPM %46%42%44%50%51%44%
Other Income001200
Interest7813192629
Depreciation121622334459
Profit before tax232734384958
Tax %21%25%14%12%13%12%
Net Profit182030334251
EPS in Rs20.5116.4020.4826.338.23
Dividend Payout %12%11%12%10%9%13%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%29%29%42%
Compounded Profit Growth%23%20%21%
Stock Price CAGR%%%%
Return on Equity%10%10%8%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Equity Capital91018161865
Reserves107161291319390789
Borrowings114180200301427455
Other Liabilities222130343756
Total Liabilities2523715396708731,364
Fixed Assets96143241317408513
CWIP4281123146217259
Investments1111018301
Other Assets114146174198231291
Total Assets2523715396708731,364
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Cash from Operating Activity3218486892118
Cash from Investing Activity-57-105-163-143-220-514
Cash from Financing Activity258811574133395
Net Cash Flow01-0-15-2
Free Cash Flow-10-86-114-64-114-90
CFO/OP88%50%76%82%84%89%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Debtor Days8187941029290
Inventory Days190316354418346221
Days Payable343534515029
Cash Conversion Cycle237368413470388282
Working Capital Days122190213239225187
ROCE %12%11%10%10%8%

Fundamentals

Market Cap₹ Cr.
Current Price₹ 3.97
Book Value₹ 137
ROCE8.18 %
ROE8.14 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)42%
Compounded Profit Growth (TTM)21%
Consolidated figures.
Profitability
Operating margin (excl. other income)42.39%
Operating margin (incl. other income)42.51%
EBITDA margin42.51%
Pre-tax margin22.31%
Net profit margin16.68%
ROE14.10%
ROCE12.12%
ROA6.49%
ROIC (approx.)7.57%
Tax rate25.24%
Other income / net worth0.08%
Growth
Sales growth (latest year)32.63%
Profit growth (latest year)10.07%
Per share
EPS (TTM)Rs 20.51
EPS (latest year)Rs 20.51
Book value per shareRs 173.09
Sales per shareRs 123.00
Cash flow per shareRs 18.01
Free cash flow per shareRs -91.26
Dividend per share (latest year)Rs 2.25
Dividends
Dividend payout10.97%
Efficiency
Asset turnover0.33x
Fixed asset turnover0.85x
Inventory turnover1.25x
Inventory days293 days
Debtor days87 days
Debtors turnover4.17x
Creditor days29 days
Cash conversion cycle282 days
Working capital days187 days
Leverage
Total debtRs 180 Cr
Cash and bankRs 2 Cr
Net debtRs 177 Cr
Debt to equity1.05x
Net debt / EBITDA3.43x
Interest coverage4.32x
Owners' fund to total sources46.01%
Debt to assets48.39%
Cash flow
Cash from Operating Activity (latest year)Rs 18 Cr
Cash from Investing Activity (latest year)Rs -105 Cr
Cash from Financing Activity (latest year)Rs 88 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -90 Cr
FCFE (approx.: FCF + change in debt)Rs -25 Cr
Cash from ops / profit, 5 years1.95x
Sales to cash flow6.83x
Statement figures
Net sales (TTM)Rs 121 Cr
Net sales (latest year)Rs 121 Cr
Operating profit excl. other income (latest year)Rs 51 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 52 Cr
PBDT (TTM)Rs 43 Cr
Profit before tax (TTM)Rs 27 Cr
Tax (latest year)Rs 7 Cr
Net profit (TTM)Rs 20 Cr
Net profit (latest year)Rs 20 Cr
Depreciation (TTM)Rs 16 Cr
Interest (TTM)Rs 8 Cr
Cost of goods sold (latest year)Rs 48 Cr
Total expenditure (latest year)Rs 70 Cr
Total income (latest year)Rs 121 Cr
Share capitalRs 10 Cr
ReservesRs 161 Cr
Shareholders' fundsRs 171 Cr
Total assetsRs 371 Cr
Net blockRs 143 Cr
Capital work in progressRs 81 Cr
InvestmentsRs 1 Cr
ReceivablesRs 29 Cr
InventoryRs 39 Cr
Other liabilitiesRs 21 Cr
Shares outstanding (crore)0.99
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 3 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

No quarterly results published.

Activity

Compare
CompanyMcap (Cr)P/EROCE
SRF Ltd71,73832.014.6 %
Deepak Fertilisers & Petrochemicals Corp Ltd16,52316.811.4 %
Tata Chemicals Ltd15,6383.42 %
Gujarat Narmada Valley Fertilizers & Chemicals Ltd8,9858.6612.0 %
Tanfac Industries Ltd7,22610723.9 %
Gujarat Alkalies & Chemicals Ltd4,60669.41.42 %
Grauer & Weil (India) Ltd3,74423.420.6 %
GHCL Ltd3,7248.1617.4 %
J.G.Chemicals Ltd2,57634.318.1 %
Thirumalai Chemicals Ltd1,834-3.15 %
I G Petrochemicals Ltd1,80122.13.11 %
Indo Borax & Chemicals Ltd1,56932.015.4 %
Innovassynth Technologies (India) Ltd1,405-16.4 %
Citurgia Biochemicals Ltd1,380%
Vikram Thermo (India) Ltd1,32030.136.2 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Jupiter Bioscience Ltd?

Jupiter Bioscience Ltd (524826) has a market capitalisation of Rs Cr. at the close.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03